Abbott Laboratories announced plans to spin off its branded drug business, and separate into two companies. Mad Money host Jim Cramer explains why it's time to buy the stock.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT